Primary Care/Hospitalist
RSSArticles
-
Nesiritide and heart failure
-
Drug safety alert issued for dronedarone
-
ACEI/ARB therapy for aortic stenosis
-
FDA actions
-
Statins do not increase risk of cancer
-
News Brief: The AMA and the Infectious Diseases Specialist: House of Delegates Update
The American Medical Association convened the biannual House of Delegates meeting in Chicago in June with more than 500 delegates from a variety of societies and organizations. -
Special Feature: Colistimethate: Risk of Serious or Fatal Medication Error
The National Medication Error Reporting Program (operated by the Institute for Safe Medication Practices [ISMP]) recently issued an alert on the potential risk of medication errors associated with dosing colistimethate for injection. -
Pharmacology Watch: FDA issues Multiple Drug Warnings
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions. -
Abstract & Commentary: Anti-staphylococcal β-lactam Antibiotics Potentiate Daptomycin Activity vs. MRSA
Seven patients were identified when DAP-ASBL therapy was used to eradicate persistent MRSA bacteremia. Isolates from 3 patients were available for in vitro study. -
Abstract & Commentary: Plasma β-glucan for the Diagnosis of Pneumocystis Pneumonia in AIDS Patients
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection (OI) in AIDS patients. Laboratory diagnosis of this life-threatening infection is based primarily upon identifying P. jirovecii cysts in respiratory secretions, a technique that is variably sensitive and requires adequate patient effort (for induced sputum examination) or an invasive test (bronchoscopy); both are quite operator dependent.